These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2422737)
21. HLA and leprosy in the pre and postgenomic eras. Geluk A; Ottenhoff TH Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267 [TBL] [Abstract][Full Text] [Related]
22. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy. Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762 [TBL] [Abstract][Full Text] [Related]
23. Excavating the surface-associated and secretory proteome of Mycobacterium leprae for identifying vaccines and diagnostic markers relevant immunodominant epitopes. Rana A; Thakur S; Bhardwaj N; Kumar D; Akhter Y Pathog Dis; 2016 Dec; 74(9):. PubMed ID: 27856491 [TBL] [Abstract][Full Text] [Related]
24. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors. Mohagheghpour N; Gelber RR; Engleman EG J Immunol; 1987 Jan; 138(2):570-4. PubMed ID: 2947952 [TBL] [Abstract][Full Text] [Related]
25. Studies on the defect in cell-mediated immunity in lepromatous leprosy using HLA-D-identical siblings. Absence of circulating suppressor cells and evidence that the defect is in the T-lymphocyte, rather than the monocyte, population. Stoner GL; Mshana RN; Touw J; Belehu A Scand J Immunol; 1982 Jan; 15(1):33-48. PubMed ID: 6176016 [TBL] [Abstract][Full Text] [Related]
27. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589 [TBL] [Abstract][Full Text] [Related]
28. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses. Nath I; Van Rood JJ; Mehra NK; Vaidya MC Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335 [TBL] [Abstract][Full Text] [Related]
29. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Misra N; Murtaza A; Walker B; Narayan NP; Misra RS; Ramesh V; Singh S; Colston MJ; Nath I Immunology; 1995 Sep; 86(1):97-103. PubMed ID: 7590888 [TBL] [Abstract][Full Text] [Related]
30. A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. Mehra V; Bloom BR; Bajardi AC; Grisso CL; Sieling PA; Alland D; Convit J; Fan XD; Hunter SW; Brennan PJ J Exp Med; 1992 Jan; 175(1):275-84. PubMed ID: 1730920 [TBL] [Abstract][Full Text] [Related]
31. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection. Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740 [TBL] [Abstract][Full Text] [Related]
32. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. Kaplan G; Gandhi RR; Weinstein DE; Levis WR; Patarroyo ME; Brennan PJ; Cohn ZA J Immunol; 1987 May; 138(9):3028-34. PubMed ID: 3106496 [TBL] [Abstract][Full Text] [Related]
33. HLA-DR-restricted antigen-induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. leprae. Mustafa AS; Qvigstad E Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):1-11. PubMed ID: 2659694 [TBL] [Abstract][Full Text] [Related]
34. The human CD1-restricted T cell repertoire is limited to cross-reactive antigens: implications for host responses against immunologically related pathogens. Sieling PA; Torrelles JB; Stenger S; Chung W; Burdick AE; Rea TH; Brennan PJ; Belisle JT; Porcelli SA; Modlin RL J Immunol; 2005 Mar; 174(5):2637-44. PubMed ID: 15728470 [TBL] [Abstract][Full Text] [Related]
35. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions. Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587 [TBL] [Abstract][Full Text] [Related]
36. Molecular mapping of interactions between a Mycobacterium leprae-specific T cell epitope, the restricting HLA-DR2 molecule, and two specific T cell receptors. Anderson DC; van Schooten WC; Janson A; Barry ME; de Vries RR J Immunol; 1990 Apr; 144(7):2459-64. PubMed ID: 1690768 [TBL] [Abstract][Full Text] [Related]
37. Human suppressor T cell clones lack CD28. Li SG; Ottenhoff TH; Van den Elsen P; Koning F; Zhang L; Mak T; De Vries RR Eur J Immunol; 1990 Jun; 20(6):1281-8. PubMed ID: 2164478 [TBL] [Abstract][Full Text] [Related]
38. Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope on 65-kDa hsp of mycobacteria. Haanen JB; Ottenhoff TH; Lai A Fat RF; Soebono H; Spits H; de Vries RR J Immunol; 1990 Dec; 145(11):3898-904. PubMed ID: 1701000 [TBL] [Abstract][Full Text] [Related]
39. Cross-reactive epitopes and HLA-restriction elements in human T cell recognition of the Mycobacterium leprae 18-kD heat shock protein. Mustafa AS; Lundin KE; Meloen RH; Oftung F Clin Exp Immunol; 2000 Apr; 120(1):85-92. PubMed ID: 10759768 [TBL] [Abstract][Full Text] [Related]
40. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Mehra V; Brennan PJ; Rada E; Convit J; Bloom BR Nature; 1984 Mar 8-14; 308(5955):194-6. PubMed ID: 6366573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]